Search results
Order by most recent / most popular / relevance
Results: 1-10 of 307
Teva Canada Innovation v. Attorney General of Canada
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
Reynolds Presto Products Inc. v. P.R.S. Mediterranean Ltd., 2013 FCA 119
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Court of Appeal has overturned a lower court decision and struck the mark NEOWEB from the register because it is confusing with the earlier
Prohibition not granted as non-infringement allegation held justified
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 18 2012
The Court heard this application and the next application consecutively and issued decisions on the same day, however, indicated that each was considered separately
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 13 2013
This case involved a dispute over ownership and alleged infringement of copyright in a number of computer software programs. The Court held that the
Default judgment not set aside due to defendant's misrepresentations
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 20 2012
The Defendants in this action brought a motion seeking a declaration that the default judgment should not be enforced against them, or, alternatively should be set aside
Definition of “innovative drug” does not include variations
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s
Motion to set aside ex parte default judgment dismissed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 20 2012
In January, the Federal Court granted default judgment to the Plaintiffs in an action for, inter alia, trade-mark infringement and passing off
Documents included in joint book for trial should be exhibits for appeal
- Borden Ladner Gervais LLP
- -
- Canada
- -
- June 11 2012
The issue to be determined relates to the contents of the appeal books
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 1 2013
The Court granted a Prohibition Order to AstraZeneca, preventing Ranbaxy from entering the market with a generic version of ompeprazole until the
Application alleging trade-mark infringement, passing off and depreciation of goodwill dismissed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 9 2012
BBM Canada brought an application alleging infringement, passing off and depreciation of goodwill with respect to its registered trade-marks by the use by Research in Motion of ‘BBM’ in association with its Blackberry Messenger service
Current Search
- Author - Beverley Moore
- Workarea - Litigation